F Aubrun1, S Monsel, O Langeron, P Coriat, B Riou. 1. Department of Anaesthesiology and Critical Care, Centre Hospitalier Universitaire Pitié-Salpêtrière, Université Pierre et Marie Curie, Paris, France.
Abstract
BACKGROUND AND OBJECTIVE: Intravenous morphine titration is used to obtain postoperative pain relief, but few studies have assessed the appropriate regimen. In a quality programme, we performed a prospective non-randomized study of morphine titration in a postanaesthesia care unit (PACU). METHODS: Four regimens of morphine titration were studied: every 10 (group 1, n = 400) or 5 min (group 2, n = 400) with a maximum of five intravenous boluses; every 5 min, without any limitation in the number of boluses (groups 3 and 4, n = 400 each); in groups 1, 2, and 3, subcutaneous morphine was administered 4 h after titration. In group 4, administration of subcutaneous morphine was allowed only 2 h after titration. A visual analogue pain scale (VAPS) > 30 mm was required to administer morphine and pain relief was defined as a VAPS < or = 30 mm. RESULTS: After morphine titration, VAPS was lower and the number of patients with pain relief was greater in patients from groups 3 and 4. Patients from group 4 had the lowest VAPS (26 +/- 17 mm) and the highest percentage of pain relief (73%) at the end of the PACU period. The number of sedated patients increased in groups 3 (62%) and 4 (61%) compared with group 1 (27%). No significant differences in morphine-related adverse effects were observed. CONCLUSION: Intravenous morphine titration every 5 min with an unlimited number of boluses and early subcutaneous administration provided the best analgesic regimen.
BACKGROUND AND OBJECTIVE: Intravenous morphine titration is used to obtain postoperative pain relief, but few studies have assessed the appropriate regimen. In a quality programme, we performed a prospective non-randomized study of morphine titration in a postanaesthesia care unit (PACU). METHODS: Four regimens of morphine titration were studied: every 10 (group 1, n = 400) or 5 min (group 2, n = 400) with a maximum of five intravenous boluses; every 5 min, without any limitation in the number of boluses (groups 3 and 4, n = 400 each); in groups 1, 2, and 3, subcutaneous morphine was administered 4 h after titration. In group 4, administration of subcutaneous morphine was allowed only 2 h after titration. A visual analogue pain scale (VAPS) > 30 mm was required to administer morphine and pain relief was defined as a VAPS < or = 30 mm. RESULTS: After morphine titration, VAPS was lower and the number of patients with pain relief was greater in patients from groups 3 and 4. Patients from group 4 had the lowest VAPS (26 +/- 17 mm) and the highest percentage of pain relief (73%) at the end of the PACU period. The number of sedated patients increased in groups 3 (62%) and 4 (61%) compared with group 1 (27%). No significant differences in morphine-related adverse effects were observed. CONCLUSION: Intravenous morphine titration every 5 min with an unlimited number of boluses and early subcutaneous administration provided the best analgesic regimen.
Authors: Erik M Helander; Bethany L Menard; Chris M Harmon; Ben K Homra; Alexander V Allain; Gregory J Bordelon; Melville Q Wyche; Ira W Padnos; Anna Lavrova; Alan D Kaye Journal: Curr Pain Headache Rep Date: 2017-01
Authors: Kitty S Chan; Wen-Hung Chen; T J Gan; Ray Hsieh; Connie Chen; Mani Lakshminarayanan; Dennis A Revicki Journal: Qual Life Res Date: 2009-10-30 Impact factor: 4.147
Authors: Szymon Bialka; Maja Copik; Andrzej Daszkiewicz; Eva Rivas; Kurt Ruetzler; Lukasz Szarpak; Hanna Misiolek Journal: J Thorac Dis Date: 2018-08 Impact factor: 2.895
Authors: Anatoli Stav; Leonid Reytman; Michael-Yohay Stav; Anton Troitsa; Mark Kirshon; Ricardo Alfici; Mickey Dudkiewicz; Ahud Sternberg Journal: Rambam Maimonides Med J Date: 2016-07-28
Authors: Jacob L Hutchins; David Leiman; Harold S Minkowitz; Maurice Jove; Karen P DiDonato; Pamela P Palmer Journal: Pain Med Date: 2018-10-01 Impact factor: 3.750